Not recruitingISRCTN14339586

Consequences of prolonged diacetylmorphine (DAM; pharmaceutical heroin) take home for individuals with severe Addiction

Research studySwitzerland

The study in practice

Understand this study

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateNot clearly listed

Recruitment status: Not recruiting
Enrollment listed in the registry: Not clearly listed
Sponsor: Arud Center for Addiction Medicine
Sponsor type: Pharmaceutical company
Study type: Other
Intervention type: Other / unclear
Study phase: Not clearly listed
Locations: Switzerland
Age range: Not clearly listed
Official registry ID: ISRCTN14339586
Official title: Show the full official title
Consequences of prolonged diacetylmorphine (DAM; pharmaceutical heroin) take home for individuals with severe Addiction

Not recruiting

Switzerland

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is Arud Center for Addiction Medicine, a pharmaceutical company.

Is this study still recruiting?

The registry lists this study as not recruiting.